Images Header 06 Investors

Investors

We create shareholder value by advancing healthcare through patented nanoscience.

$2.46 CAD

(as of market close Dec 6)

TSX: Zentek Ltd. (ZEN.V)

0.16 (6.96%)

$1.82 USD

(as of market close Dec 6)

NASDAQ: Zentek Ltd. (ZTEK)

0.08 (4.71%)

Why invest in Zentek?

Highly scalable and differentiated opportunities.

Zentek is at the forefront of developing and commercializing next-gen, nanotechnology-enabled healthcare solutions that improve people’s lives. Our IP for potential game-changing healthcare technologies in the areas of prevention, detection and treatment are a key differentiator and value driver.

Focus Areas

Research

Next-gen defense to combat transmission and infection.

Along with our own laboratory, we also work with over 100 researchers in a dozen Universities across Canada and globally who are focused on graphene and nanotechnology research. Graphene has enormous potential to enhance numerous existing products and technologies

Development

Patent-pending nanotechnologies are currently being researched to drive value.

Our focus is on bringing next-generation graphene nanotechnologies to market by carefully evaluating and prioritizing our intellectual property and innovations at the research phase.

Commercialization

Improving lives through graphene-based, advanced nanotechnologies

Our patent-pending, next generation antimicrobial coating defense combats transmission and infection. ZenGUARD™ enhances the filtration of pathogens to reduce the risk of transmission in indoor spaces and higher risk work environments.

For further information:

Ryan Shacklock

VP, Strategy, Business Development & Investor Relations

Corporate Video

From Complex Challenges comes Complex Solutions

Financials

Subscribe for Updates

Interested in recieving press releases directly to your inbox? Subscribe to Zentek's mailing list for all the latest news.